Based on the aforementioned findings, we subsequently concluded that silencing ANRIL suppresses cell proliferation, cell invasion ability, while acting to promote the apoptosis of retinoblastoma cells with a possible involvement of the ATM-E2F1 signaling pathway. The gene discussed is CDKN2B-AS1; the disease is retinoblastoma.